Correlation between cerebral small vessel disease biomarkers and plasma GFAP in participants of the encephalopathy and memory clinic cohort, in Thailand: A Story from a Middle‐Income Country

The total CSVD score and plasma GFAP showed a stronger positive correlation in the non-AD group than in the AD group. After adjusting for p-tau 217, an AD biomarker, the correlation between total CSVD score and plasma GFAP became stronger. These findings suggest that plasma GFAP alone may have limitations in assessing CSVD burden in AD due to shared mechanisms and biomarkers. Further validation of other potential VCID fluid biomarkers is warranted.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70856_098874
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correlation between cerebral small vessel disease biomarkers and plasma GFAP in participants of the encephalopathy and memory clinic cohort, in Thailand: A Story from a Middle‐Income Country

Prawit Oangkhana, Watayuth Luechaipanit, Thachamai Smitasiri, Thanakit Pongpitakmetha et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Correlation between cerebral small vessel disease biomarkers and plasma GFAP in participants of the encephalopathy and memory clinic cohort, in Thailand: A Story from a Middle‐Income Country

Prawit Oangkhana, Watayuth Luechaipanit, Thachamai Smitasiri, Thanakit Pongpitakmetha, Kittithatch Booncharoen, Yuttachai Likitjaroen, Jedsada Khieukhajee, Adipa Chongsuksantikul, Tatchaporn Ongphichetmetha, Sekh Thanprasertsuk, Poosanu Thanapornsangsuth, Thanaporn Haethaisong, Juthamas Rianaree, Thanapoom Taweephol, Nattanich Pornteparak
article en

Abstract

The total CSVD score and plasma GFAP showed a stronger positive correlation in the non-AD group than in the AD group. After adjusting for p-tau 217, an AD biomarker, the correlation between total CSVD score and plasma GFAP became stronger. These findings suggest that plasma GFAP alone may have limitations in assessing CSVD burden in AD due to shared mechanisms and biomarkers. Further validation of other potential VCID fluid biomarkers is warranted.

Alzheimer s & DementiaVol. 21(S2)
Thai Red Cross Society (TH), Siriraj Hospital (TH), Chulalongkorn University (TH), Mahidol University (TH), Bangkok Hospital (TH), King Chulalongkorn Memorial Hospital (TH), Phramongkutklao Hospital (TH), Ministry of Science and Technology Thailand (TH), Neurological Institute of Thailand (TH)
No poverty
Openalex Percentile: Top 34%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.